Vioxx Research Today is a free monthly online journal that collates and summarizes the latest research about Vioxx, including details on osteoarthritis, side-effects, trials, stroke, heart attack.

Etoricoxib-Induced Erythema-Multiforme-Like Eruption.

Thirion L, Nikkels AF, Piérard GE

Department of Dermatopathology, University Medical Center of Liège, Liège, Belgium.

Etoricoxib is a new, highly selective cyclooxygenase (COX) 2 inhibitor, reported to have an increased cutaneous and systemic safety profile compared to the previous COX-2 inhibitors, including celecoxib, rofecoxib and valdecoxib. To the best of our knowledge, the present case of etoricoxib-induced erythema-multiforme-like eruption is the first reported in the literature. Copyright (c) 2008 S. Karger AG, Basel.

Published 9 January 2008 in Dermatology, 216(3): 227-228.
Full-text of this article is available online (may require subscription).

© 2004-2008 Vioxx Research Today. All Rights Reserved.